Format

Send to

Choose Destination
Cancer Res. 2011 Jul 1;71(13):4344-51. doi: 10.1158/0008-5472.CAN-10-3827. Epub 2011 Apr 11.

Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors.

Author information

1
Friedrich Miescher Institute for Biomedical Research, Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, Basel, Switzerland.

Abstract

The phosphoinositide 3-kinase (PI3K) signaling cascade, a key mediator of cellular survival, growth, and metabolism, is frequently altered in human cancer. Activating mutations in PIK3CA, which encodes the α-catalytic subunit of PI3K, occur in approximately 30% of breast cancers. These mutations result in constitutive activity of the enzyme and are oncogenic, but it is not known whether they are sufficient to induce mammary carcinomas in mice. In the present study, we show that the expression of mutant PIK3CA H1047R in the luminal mammary epithelium evokes heterogeneous tumors that express luminal and basal markers and are positive for the estrogen receptor. Our results suggest that the PIK3CA H1047R oncogene targets a multipotent progenitor cell and, furthermore, show that this model recapitulates features of human breast tumors with PIK3CA H1047R.

PMID:
21482677
DOI:
10.1158/0008-5472.CAN-10-3827
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center